Amanote Research

Amanote Research

    RegisterSign In

Reply: Glucocorticoid Use and Skin Cancers

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6601222
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

August 26, 2003

Authors
M R KaragasD W Nierenberg
Publisher

Springer Science and Business Media LLC


Related search

Non-Melanoma Skin Cancers and Glucocorticoid Therapy

British Journal of Cancer
Cancer ResearchOncology
2001English

Sun Exposure, Skin Cancers and Related Skin Conditions

Journal of Epidemiology
MedicineEpidemiology
1999English

727 Use of PI3K/mTOR/Akt Inhibitors as Skin Protectors to Spare Skin From Glucocorticoid-Induced Atrophy

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Deletion of the Glucocorticoid Receptor Chaperone FKBP51 Prevents Glucocorticoid-Induced Skin Atrophy

Oncotarget
Oncology
2018English

Keratinocyte Skin Cancers in the Spotlight

British Journal of Dermatology
DermatologyMedicine
2017English

Increased Glucocorticoid Activation During Mouse Skin Wound Healing

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Inpatient Glucocorticoid Use: Beneficencevsnon-Maleficence

British journal of hospital medicine (London, England : 2005)
Medicine
2014English

Melanoma and Skin Cancers in Airline Pilots and Cabin Crew

British Journal of Dermatology
DermatologyMedicine
2019English

All Skin Cancers Are Not Created Equal

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy